Trials / Completed
CompletedNCT02326636
Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- University of California, Irvine · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to investigate the efficacy of transplanting screened donor fecal material in treating patients with recurrent Clostridium difficile infection. Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy or enema and their response will be evaluated by symptom questionnaire and stool testing for Clostridium difficile at 4 weeks after the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fecal Microbial Transplantation | Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy or enema. |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2018-10-26
- Completion
- 2018-10-26
- First posted
- 2014-12-29
- Last updated
- 2023-08-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02326636. Inclusion in this directory is not an endorsement.